EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Curcumin encapsulated in PAMAM dendrimers for the therapeutic treatment of ischemic stroke in rats

Justin Stadler, Lucas G Garmo, David Doyle, Chin-I Cheng, Garrett Richardson, Zain Waheed, Tim Tofan, Bhairavi Srinageshwar, Ajit Sharma, Robert B Petersen, Gary L Dunbar, Julien Rossignol

Frontiers in Cell and Developmental Biology · 06.01.2025 · 12

DOI: 10.3389/fcell.2024.1467417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 06.01.2025. Verfasst von Justin Stadler und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Central Michigan University, Mount Pleasant, MI, United States. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ischemic stroke is a devastating neurovascular condition that occurs when cerebral tissue fails to receive an adequate supply of oxygen. Despite being a leading cause of death and disability worldwide, therapeutic interventions are currently limited. Polyamidoamine (PAMAM) dendrimers are nanomolecules commonly used in biomedical applications due to their ability to encapsulate small-molecules and improve their pharmacokinetic properties. Curcumin is known to have anti-inflammatory and antioxidant effects yet suffers from poor solubility and bioavailability. The purpose of this study is to investigate the efficacy of curcumin encapsulated in PAMAM dendrimers as a potential therapeutic treatment for ischemic stroke by studying post-stroke lesion size, astrocyte reactivity, and functional recovery in a rat model of cerebral ischemia.

Methods

Forty-eight male and female Sprague-Dawley rats (280–380 g) underwent either a 90-min middle cerebral artery occlusion (MCAo) or sham surgery before receiving one of four treatments: (1) Hanks’ balanced salt solution (HBSS) control, (2) empty dendrimer control, (3) curcumin control, or (4) curcumin encapsulated in PAMAM dendrimer. Neurobehavioral outcomes were evaluated at 1-, 3-, 5-, and 7-day post-surgery, after which animals were euthanized on day 8 to assess infarct volume and GFAP immunoreactivity.

Results

Animals that received formulations containing dendrimers (curcumin encapsulated in dendrimers or empty dendrimers) demonstrated significantly lower levels of GFAP immunoreactivity and improved functional recovery, including weight and neurobehavioral scores, compared to the formulations that did not contain dendrimers (curcumin and HBSS control). Additionally, the dendrimer-curcumin treatment group exhibited a significantly improved paw laterality index over the course of the study compared with the other three treatment groups.

Conclusion

Although the post-stroke administration of curcumin encapsulated in PAMAM dendrimers modulates the astrocytic response and promotes functional recovery following ischemic stroke in rats, its therapeutic benefits may be driven by PAMAM dendrimers as the empty dendrimer treatment group also showed significant improvements post-stroke. Further investigation regarding PAMAM dendrimers in treating neuroinflammatory conditions remains warranted.

Schlagwörter

Stichwörter der Autor:innen

PAMAM dendrimersblood-brain barrier (BBB)curcuminischemic strokeneuroinflammation

Autor:innen und Institutionen

  • College of Medicine, Central Michigan University, Mount Pleasant, MI, United States.
  • Program in Neuroscience, Central Michigan University, Mount Pleasant, MI, United States.
  • Field Neurosciences Institute Laboratory for Restorative Neurology, Central Michigan University, Mount Pleasant, MI, United States.
  • Department of Statistics, Actuarial and Data Science, Central Michigan University, Mt. Pleasant, MI, United States.
  • School of Business, Wayne State University, Detroit, MI, United States.
  • Department of Chemistry & Biochemistry, Central Michigan University, Mount Pleasant, MI, United States.

Förderung

  • American Heart Association

Zitieren

APA

Stadler, J., Garmo, L. G., Doyle, D., Cheng, C. I., Richardson, G., Waheed, Z., Tofan, T., Srinageshwar, B., Sharma, A., Petersen, R. B., Dunbar, G. L., & Rossignol, J. (2025). Curcumin encapsulated in PAMAM dendrimers for the therapeutic treatment of ischemic stroke in rats. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1467417

Vancouver

Stadler J, Garmo LG, Doyle D, Cheng CI, Richardson G, Waheed Z, et al. Curcumin encapsulated in PAMAM dendrimers for the therapeutic treatment of ischemic stroke in rats. Frontiers in Cell and Developmental Biology. 2025;12. doi:10.3389/fcell.2024.1467417

BibTeX
@article{Stadler2025,
  author = {Stadler, Justin and Garmo, Lucas G and Doyle, David and Cheng, Chin-I and Richardson, Garrett and Waheed, Zain and Tofan, Tim and Srinageshwar, Bhairavi and Sharma, Ajit and Petersen, Robert B and Dunbar, Gary L and Rossignol, Julien},
  title = {Curcumin encapsulated in PAMAM dendrimers for the therapeutic treatment of ischemic stroke in rats},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2025},
  volume = {12},
  doi = {10.3389/fcell.2024.1467417}
}
Kostenlos starten →